Johnson & Johnson Innovation Presents: 2023 Blue Knight Symposium (Applications Due by May 8th)

Join us for a global conversation with innovators, investors, partners and thought leaders to discover and accelerate next-gen potential solutions for future pandemics, emerging pathogens, and other known and unknown threats. This event is part of  BLUE KNIGHT™, a joint initiative between Johnson & Johnson Innovation – JLABS (JLABS) and the Biomedical Advanced Research and Development Authority (BARDA), within the U.S. Department of Health and Human Services.  This year's Symposium will be hosted in association with the 2023 BIO International Convention.

Attendance is limited so secure your spot and RSVP today to take part in this global event. More information on this year's Symposium will be announced shortly. In the meantime, learn more about the engagement opportunities we have available this year for early-stage companies, investors, funders and strategic partners below. 

This program is a product of a collaboration between Johnson & Johnson Innovation – JLABS (JLABS) and the Biomedical Advanced Research and Development Authority (BARDA), part of Administration for Strategic Preparedness and Response at the U.S. Department of Health and Human Services.

BLUE KNIGHT™ is a joint initiative between Johnson & Johnson Innovation – JLABS (JLABS) and the Biomedical Advanced Research and Development Authority (BARDA), part of the Administration for Strategic Preparedness and Response at the U.S. Department of Health and Human Services. This collaboration aims to stimulate the innovation and incubation of science and technologies that may improve health security and response by supporting companies focused on public health threats and emerging infectious diseases. 

To Register: 2023 BLUE KNIGHT™ Symposium (splashthat.com)

Find out more about BARDA and its mission at www.medicalcountermeasures.gov.